Michael Needle
2017
In 2017, Michael Needle earned a total compensation of $813.5K as Chief Medical Officer at AVEO Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $222,718 |
---|---|
Option Awards | $123,827 |
Salary | $421,814 |
Other | $45,112 |
Total | $813,471 |
Needle received $421.8K in salary, accounting for 52% of the total pay in 2017.
Needle also received $222.7K in non-equity incentive plan, $123.8K in option awards and $45.1K in other compensation.
Rankings
In 2017, Michael Needle's compensation ranked 9,954th out of 14,666 executives tracked by ExecPay. In other words, Needle earned more than 32.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,954 out of 14,666 | 32nd |
Division Manufacturing | 3,853 out of 5,772 | 33rd |
Major group Chemicals And Allied Products | 1,343 out of 2,075 | 35th |
Industry group Drugs | 1,088 out of 1,731 | 37th |
Industry Pharmaceutical Preparations | 850 out of 1,333 | 36th |
Source: SEC filing on April 30, 2019.
Needle's colleagues
We found three more compensation records of executives who worked with Michael Needle at AVEO Pharmaceuticals in 2017.
News
AVEO Pharmaceuticals CEO Michael Bailey's 2021 pay jumps 84% to $2.9M
April 26, 2022
AVEO Pharmaceuticals CEO Michael Bailey's 2020 pay rises 1% to $1.6M
April 28, 2021
AVEO Pharmaceuticals CEO Michael Bailey's 2019 pay falls 49% to $1.6M
April 28, 2020
AVEO Pharmaceuticals CEO Michael Bailey's 2018 pay jumps 127% to $3.1M
April 30, 2019